Both in Pharmaceuticals
Madrigal Pharmaceuticals vs Corcept Therapeutics
Over the past year MDGL returned −3.9% and CORT returned +10.5%; their daily moves had a correlation of 0.09.
MDGL −3.9% CORT +10.5%Growth of $1, one year, split-adjusted
| Metric | MDGL | CORT |
|---|---|---|
| Price | $396.32 | $81.93 |
| Market cap | $9.16B | $8.86B |
| Today | −8.08% | +1.83% |
| 1 month | −19.7% | −32.9% |
| 6 months | −21.1% | +59.6% |
| Year to date | −31.9% | +135.4% |
| 1 year | −5.4% | +11.5% |
| Revenue growth (YoY) | +71.2% | +31.7% |
| Gross margin | 100.0% | 98.4% |
| Net margin | −15.9% | 16.8% |
| P/E (TTM) | — | 162.5× |
| Price / sales | 7.1× | 10.7× |
| Net cash | $498.0M | $308.2M |
| Dividend yield | — | — |
| Volatility (60d) | 35.1% | 59.3% |
| Short % of float | 14.7% | 9.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).